{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0378-4162",
      "generic_name": "atovaquone and proguanil hydrochloride",
      "labeler_name": "Mylan Pharmaceuticals Inc.",
      "brand_name": "Atovaquone and Proguanil Hydrochloride",
      "active_ingredients": [
        {
          "name": "ATOVAQUONE",
          "strength": "250 mg/1"
        },
        {
          "name": "PROGUANIL HYDROCHLORIDE",
          "strength": "100 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0378-4162-01",
          "description": "100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4162-01)",
          "marketing_start_date": "20140528",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "bf8ac578-e07c-44b0-bc85-47919e3a848c",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20140528",
      "product_id": "0378-4162_bf8ac578-e07c-44b0-bc85-47919e3a848c",
      "application_number": "ANDA202362",
      "brand_name_base": "Atovaquone and Proguanil Hydrochloride",
      "pharm_class": [
        "Antimalarial [EPC]",
        "Antimalarial [EPC]",
        "Antiprotozoal [EPC]",
        "Dihydrofolate Reductase Inhibitors [MoA]"
      ]
    }
  ]
}